Vita Resources (ASX:VTA) has raised A$2.9 million at a 22% discount to fund gold and critical minerals exploration across four jurisdictions.
Charlie Youlden
Southern Cross Electrical (ASX:SXE) raises A$150m, upgrades FY26 EBITDA to A$75m and initiates FY27 guidance at A$100m on data centre awards.
Archer Materials (ASX:AXE) reaffirms a Q3 2026 qubit demonstration and starts full-wafer graphene runs while reviewing acquisitions and IP deals.
Iondrive (ASX:ION) hits 93.5% dysprosium recovery and the TEA assumption looks suddenly conservative
Iondrive (ASX:ION) reports 93.5% dysprosium recovery from US e-waste, nearly tripling the original TEA assumption and reshaping its magnet recycling economics.
Theta Gold Mines (ASX:TGM) has settled its US$90m bond and parked proceeds in escrow, shifting the story from funding risk to execution risk.
1414 Degrees (ASX:14D) has cleared AEMO on its Aurora BESS, moved into ElectraNet TCA talks, and drawn data centre due diligence.
Sigma Healthcare (ASX:SIG) has walked away from the Boots sale process, signalling capital discipline and shifting its UK growth onto the smaller Greenlight MoU.
IperionX (ASX:IPX) acquires Camden Tennessee assets from Covia for US$3 million, consolidating its position adjacent to the Titan critical minerals project.
Fast money has a loud voice. It appears in viral posts, lucky screenshots, sudden market stories, and friendly advice that sounds almost too easy. The promise is simple: move quickly, take a bold risk, and watch money grow overnight. Long-term investing speaks differently. It is quieter, slower, and less glamorous, but history has shown that…
SpaceX (NSDQ:SPCX) prices its IPO at US$135 per share, with the orbital AI compute pitch quietly anchoring the valuation case.
